Report Details

Our latest pharma report - Nuclear Medicine Imaging Devices: Global Market Prospects 2012-2022 - offers a comprehensive view of the global nuclear medicine imaging systems market. The report analyses recent trends in this market and anticipates the progression in the market over the next decade with global, regional and submarket forecasts. The report also reveals the market's strengths and weaknesses, revealing areas that will experience growth and present new business opportunities. Visiongain analyses predict the global value of the nuclear medicine imaging systems market in 2011 to be worth $1.5bn. Growth in this market will be driven by new technology and varied uses of the technology.

Despite experiencing a decline in sales volume and reduced demand in the aftermath of the global economic recession, the nuclear medicine market recovered well, and has seen strong growth in recent years. Much of this growth has been linked to the advent of hybrid units, such as positron emission tomography/computed tomography (PET/CT) scans, where both anatomical and functional images can be captured. For example, the combination of Positron Emission Tomography (PET) with other imaging modalities, such as MRI (Magnetic Resonance Imaging) has allowed for the imaging of cartilage damage, previously thought unreliable.

Nuclear Medicine Imaging Devices: Market Global Market Prospects 2012-2022report forecasts the size and value of leading national/regional markets including the US, Europe, Japan, India and China. For each of these, visiongain identifies prevailing trends and strategies that will steer this diagnostic technology over the forecast period. Developed nuclear medicine markets such as the US and UK are highly saturated and the focus is likely to be towards upgrading stand-alone PET and SPECT system with fully integrated hybrid units, that offer a high level of anatomical and functional detail. Emerging countries such as China and India will offer more opportunity, due a lack of nuclear medicine facilities and technologies, and increased healthcare spending. It has been predicted that healthcare investment in these countries is expected to double in the next seven years.

How will the nuclear medicine imaging systems market develop this decade? Which regions offer the most significant growth opportunities between 2012 and 2022? Which of the nuclear medicine based imaging devices are growing most strongly? Who are the leading companies in the nuclear medicine imaging systems market? What are some promising technological developments in the market? 

Visiongain answers these critical questions and many more through the in-depth analyses that are presented in this report.

Why you should buy Nuclear Medicine Imaging Devices: Global Market Prospects 2012-2022

In this report, you will receive the following benefits in particular:
• You will receive our assessment of the current market for nuclear medicine imaging systems, with respect to the leading segments, companies and national markets
• You will discover sales trends for the overall nuclear medicine imaging systems market from 2011 to 2022 - seeing where commercial growth will occur
• You will discover sales trends for the Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) market from 2011 to 2022, with detailed discussions of market potential
• You will receive sales forecasts for leading national/regional markets (US, Europe, Japan, India and China), with informed discussion
• You will assess leading manufacturers and products in the nuclear medicine imaging systems market, with information on the pipeline products
• You will examine the strengths, weaknesses, opportunities and threats (SWOT analysis) facing the nuclear medicine imaging systems market from 2012 onwards
• You will be able to investigate competition and opportunities influencing the n

Table Of Contents

Table of Contents

1.      Executive Summary
1.1 Sector Highlights
1.2 Aims, Scope and Format of the Report
1.3 Chapter Outline
1.4 Research and Analysis Methods
1.5 Glossary of Terms Related to Report

2. Introduction to Nuclear Medicine
2.1 Nuclear Medicine
2.1.1 History of Nuclear Medicine
2.2 Techniques of Nuclear Medicine
2.2.1 Diagnostic Medical Imaging
2.2.2 Interventional Nuclear Medicine

3. The Nuclear Medicine Market, 2010-2022
3.1 The Global Medical and Diagnostic Imaging Market, 2010
3.1.1 Medical And Diagnostic Imaging: Market Trends 2010-2022
3.2 Nuclear Medicine Market, 2010
3.3 Nuclear Medicine Market Forecast, 2011-2022
3.3.1 Nuclear Medicine: Market Trends, 2012-2022

4. Positron Emission Tomography Market, 2010-2022
4.1 Positron Emission Tomography (PET)
4.1.1 History of PET
4.2 How It Works
4.3 Types of PET Scans
4.3.1 PET/CT
4.3.2 PET/MRI
4.4 Applications of PET
4.5 Limitations of PET
4.6 PET Market, 2010
4.7 PET Market Forecast, 2011-2022
4.7.1 PET: Market Trends, 2012-2022
4.8 PET Devices Currently In Market
4.8.1 GE Healthcare
4.8.2 Philips
4.8.3 Siemens

5. Single Photon Emission Computed Tomography Market, 2010-2022
5.1 Single Photon Emission Computed Tomography (SPECT)
5.1.1 History of SPECT
5.2 How it Works
5.3 Types of SPECT Scans
5.3.1 SPECT/CT
5.3.2 SPECT/MRI
5.4 Applications of SPECT
5.4.1 Cardiology
5.4.2 Neurology
5.4.3 Oncology
5.5 Limitations of SPECT
5.6 SPECT Market, 2010
5.7 SPECT Market Forecast, 2011-2022
5.7.1 SPECT: Market Trends, 2012-2022
5.7.1.1 Cost Effective
5.7.1.2 Hybrid Scanning to Drive SPECT Market
5.7.1.3 Increased Approval of New Radiopharmaceuticals
5.8 SPECT Devices Currently In Market
5.8.1 GE Healthcare
5.8.2 Philips
5.8.3 Siemens

6. Leading Companies In The Nuclear Medicine Market, 2010
6.1 Intensively Competitive Market
6.2 Nuclear Medicine Market: Breakdown by Company, 2010
6.3 GE Healthcare
6.3.1 Sales and Recent Performance Analysis, 2010
6.3.1.1 Technology Sector
6.3.2 New SPECT System Promises Lower Doses
6.4 Siemens Healthcare
6.4.1 Sales And Recent Performance Analysis, 2010
6.4.1.1 Healthcare Sector
6.4.2 New Technology To Provide HD Imaging
6.5 Philips Healthcare
6.5.1 Sales and Recent Performance Analysis, 2010
6.5.1.1 Healthcare Sector
6.5.2 FDA Clearance For Philips Hybrid Technology
6.6 Other Companies

7. Leading National Nuclear Medicine Markets, 2010
7.1 Regional Breakdown of The Global Nuclear Medicine Market, 2010
7.2 The Global Nuclear Medicine Market: Regional Forecast 2012-2022
7.3 The US Market
7.4 The European Market
7.4.1 Germany and France
7.4.2 Italy
7.4.3 Spain
7.4.4 U.K
7.5 The Japanese Market
7.6 The Indian Market
7.7 The Chinese Market

8. SWOT Analysis of the Nuclear Medicine Market, 2012
8.1 Nuclear Medicine: Industry Trends
8.2 Strengths
8.2.1 Patient Demographics
8.2.2 Safer Compared to Competitive Technologies
8.3 Weaknesses
8.3.1 Regulatory Board Approvals
8.3.2 Issues With Protocols
8.3.3 Healthcare Cutbacks
8.4 Opportunities
8.4.1 Growth in SPECT/CT Imaging
8.4.2 Globalisation
8.5 Threats
8.5.1 Medical Device Excise Tax
8.5.2 The Radioisotope Shortage

9. Technological Developments In Nuclear Medicine Imaging Market
9.1 Innovative Technology Drives the Market
9.2 New Radiotracers
9.2.1 For Use In Alzheimer's disease
9.2.2 For Use In Breast Cancer
9.3 3D Imaging
9.4 Mobile Applications
9.5 Silicon Photomultipliers (SiPMs)

10. Conclusions
10.1 Overview
10.2 SPECT Exams Will Remain the Largest Segment
10.3 Prominent Companies in the Market
10.4 World Market Forecasts
10.5 Future Outlook and Concluding Remarks

Appendix A
Appendix B
Visiongain report

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Future Horizons and Growth Strategies in the Global Diagnostic Imaging Market 2014: Strategic Assessments of Leading Suppliers

Future Horizons and Growth Strategies in the Global Diagnostic Imaging Market 2014: Strategic Assessments of Leading Suppliers

  • $ 14 500
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $14,500.  Individual company assessments $2,450.  The report is available by company, section, market segment, and can be custom-tailored to your specific information needs and budget. ...

Future Horizons and Growth Strategies in the Global Ultrasound Market 2014: Strategic Assessments of Leading Suppliers

Future Horizons and Growth Strategies in the Global Ultrasound Market 2014: Strategic Assessments of Leading Suppliers

  • $ 12 500
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $12,500.  Individual company assessments $1,850.  The report is available by company, section, market segment, and can be custom-tailored to your specific information needs and budget. ...

Future Horizons and Growth Strategies in the Global MRI Market 2014: Strategic Assessments of Leading Suppliers

Future Horizons and Growth Strategies in the Global MRI Market 2014: Strategic Assessments of Leading Suppliers

  • $ 7 400
  • Industry report
  • August 2014
  • by Venture Planning Group

This report provides diagnostic imaging industry executives with strategically significant competitor information, analysis and insight crucial to the development and implementation of effective business, ...

Global Bone Densitometers Market

September 2014 $ 4 950

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.